• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS ELECSYS TSH ASSAY; RADIOIMMUNOASSAY, THYROID-STIMULATING HORMONE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS ELECSYS TSH ASSAY; RADIOIMMUNOASSAY, THYROID-STIMULATING HORMONE Back to Search Results
Model Number TSH
Device Problem High Test Results (2457)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 10/01/2020
Event Type  malfunction  
Manufacturer Narrative
This event occurred in (b)(6).The patient's samples were requested and submitted for an investigation.The investigation is ongoing.
 
Event Description
The initial reporter received questionable elecsys tsh assay results for one patient tested on a cobas 8000 e 801 module.The serial number of the e 801 module was requested but not provided.The patient had two samples collected, on (b)(6) 2020 and (b)(6) 2020.The patient's tsh results were reported outside the laboratory and the physician did not believe the results.The customer performed further testing with the patient's samples on a siemens analyzer and a beckman coulter dsi analyzer.
 
Manufacturer Narrative
On (b)(6) 2020, the customer reported the patient had a new sample collected.The patient's results were tsh 26 uiu/ml with a data flag, ft4 0.94 ng/dl, and ft3 2.91 pg/ml.Also, the customer reported "during the last weeks no further thyroxin was taken by patient." the customer's calibration and qc data were requested but not provided.The investigation reproduced the customer's tsh results.Upon further investigation of the patient samples, an interferent against a component of the reagent was confirmed, ru-label.This interference is covered in product labeling: "in rare cases, interference due to extremely high titers of antibodies to analyte-specific antibodies, streptavidin or ruthenium can occur.These effects are minimized by suitable test design.For diagnostic purposes, the results should always be assessed in conjunction with the patient¿s medical history, clinical examination and other findings." the investigation did not identify a product problem.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELECSYS TSH ASSAY
Type of Device
RADIOIMMUNOASSAY, THYROID-STIMULATING HORMONE
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
MDR Report Key10778755
MDR Text Key214394657
Report Number1823260-2020-02756
Device Sequence Number1
Product Code JLW
Combination Product (y/n)N
PMA/PMN Number
K961491
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Type of Report Initial,Followup
Report Date 01/29/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/03/2020
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date09/30/2021
Device Model NumberTSH
Device Catalogue Number08443432190
Device Lot Number47973901
Was Device Available for Evaluation? Yes
Date Manufacturer Received10/13/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
L-THYROXINE; L-THYROXINE
Patient Age45 YR
-
-